中文

← All funding rounds

Gaowei Yiyao

Also known as Groovy Medicine

ChinaDrug discoveryHangzhou, ChinaFounded 2022Private

Mines protein-interaction and other high-dimensional biology data with its own models to find drug targets others treat as undruggable, then runs its own small-molecule and antibody programmes. Its GROOVY platform found the target behind GW-01, a Notch-pathway inhibitor now in Phase I; ACUMEN maps pairs of neighbouring cell-surface proteins for bispecifics and NEXUS looks for tumour neoantigens.

Disclosed total-
Rounds on record1
Latest roundundisclosed; PEdaily says the company has raised several hundred million yuan so far this yearPre-A · 2026-10-14
Last stated valuationNone stated
Investors named8
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its datePre-A
Closed roundNot on the dollar scale (a range, or no rate)

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-10-14Pre-A
    Round

    undisclosed; PEdaily says the company has raised several hundred million yuan so far this year

    For: developing the AI target-discovery platform and its outside collaborations, the Phase I study of GW-01, and preclinical work on new programmes

    Models and platformToward the clinic

    The company announced it through PEdaily, which quotes founder Xu Li and four of the investors. The body gives no round size, only that the company has raised several hundred million yuan so far this year; PEdaily's own 'investor reading' box calls it a Pre-A of several hundred million yuan, which the announcement itself does not say, so no amount is recorded here. No valuation. No company website was found, so the English name here is the pinyin of the Chinese one; EqualOcean rendered it Groovy Medicine when it reported the 2023 angel round, which is not recorded here.

    Co-lead · Huatai GenScript FundCo-lead · Orient JiafuGuofang CapitalRuili InvestmentChuchang FundExisting investor · Xinghua DingliExisting investor · West Lake InnovationExisting investor · GF Xinde

    Advisers: Qifeng Capital (exclusive financial adviser)

    Announced by the company · news.pedaily.cn ↗On the timeline →

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

Its investors also backed

Other companies on this page whose rounds name the same investor.